HIV-positive children on highly active antiretroviral therapy (HAART) "may need to be revaccinated to maintain their immunity against preventable childhood diseases," according to researchers from the Johns Hopkins Bloomberg School of Public Health, HealthDay/BusinessWeek reports. After reviewing 38 studies, researchers found that children on HAART "had poorer responses to vaccines than do uninfected children," said study co-author William Moss. The children "respond well to revaccination," and the researchers recommend vaccination strategies be developed in regions with a high prevalence of HIV, the news service writes (9/8).
Back to other news for September 2010
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy